Raltegravir's interaction profile is its defining practical advantage. It is not handled by the liver enzyme system responsible for most drug interactions in HIV medicine.
Why does it interact so little?
Because it is cleared mainly by a process called glucuronidation rather than by CYP3A4. It neither inhibits nor induces that enzyme, so it leaves the levels of most other medicines alone and is largely unaffected by them.
Why does that matter?
Because it makes raltegravir a sensible choice for someone taking several medicines for other conditions. Where a boosted regimen would create a long list of problems, this one creates almost none.
What is the main interaction?
Metal ions. Antacids containing aluminium or magnesium reduce raltegravir levels substantially and are generally not recommended alongside it, rather than simply needing spacing.
What about calcium, iron and zinc?
Calcium carbonate can be taken with the twice-daily formulation and is not recommended with the once-daily one. Iron and zinc supplements and multivitamins need spacing. The advice differs by formulation, so ask which applies to you.
What about rifampicin?
It reduces raltegravir levels and the answer is to double the dose to 800mg twice daily rather than avoid the combination. That makes raltegravir usable alongside tuberculosis treatment, which is a substantial advantage.
What other inducers matter?
Some anticonvulsants and St John's wort reduce levels. These should be checked rather than assumed compatible, though the list is much shorter than for most antiretrovirals.
Does it interact with hormone therapy?
No, in either direction. Raltegravir does not affect oestradiol or testosterone levels, and gender-affirming hormone therapy does not reduce its effectiveness.
What about contraception?
No significant interaction with hormonal contraception, unlike efavirenz and boosted regimens where the picture is more complicated.
What about recreational drugs?
No significant interaction. Raltegravir does not block the enzyme that clears MDMA, methamphetamine, mephedrone or ketamine. For anyone whose life includes these, that is a meaningful safety difference from boosted regimens.
What about statins?
No significant interaction, which contrasts sharply with boosted regimens where several statins are contraindicated or dose-limited. Both drugs can cause muscle problems, so unexplained muscle pain on the combination is worth reporting.
What about acid-reducing medicines?
Proton pump inhibitors raise raltegravir levels somewhat, which is generally not clinically significant. This contrasts with atazanavir and rilpivirine, where acid suppression is a serious problem.
What about alcohol?
No direct interaction. The practical concerns are missed doses and vomiting rather than anything pharmacological.
What about other HIV medicines?
It combines readily with essentially all of them, which is why it appears in complex salvage regimens. Overlap with other integrase inhibitors is avoided, since they share a resistance pathway.
How do you check a combination?
The University of Liverpool interaction checker covers antiretrovirals against prescription, over-the-counter and recreational drugs. A clinic pharmacist will check without an appointment in a couple of minutes.
What about things you would not think of as medicines?
Indigestion remedies are the specific concern here, along with multivitamins and herbal products. If you take anything regularly, including things bought without a prescription, mention it.